Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	MAPK signaling pathway	4/294	0.0003034351122757725	0.013958015164685537	17.880459770114943	-49.762697732575255	NF1;RASA1;TEK;TGFB1
KEGG_2021_Human	Colorectal cancer	2/86	0.00476943508022695	0.032623549744531265	23.761904761904763	-31.205674037146366	SMAD4;TGFB1
KEGG_2021_Human	TGF-beta signaling pathway	2/94	0.005673660825135872	0.032623549744531265	21.67391304347826	-28.742216935482162	SMAD4;TGFB1
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.032623549744531265	21.914835164835164	-29.03004575134454	TEK;TGFB1
KEGG_2021_Human	Cytokine-cytokine receptor interaction	3/295	0.004778958454651453	0.032623549744531265	11.412915851272016	-23.74866982495136	ACVRL1;GDF2;TGFB1
KEGG_2021_Human	Ras signaling pathway	3/232	0.0024164136009215383	0.032623549744531265	14.670617592014972	-30.966105875434415	NF1;RASA1;TEK
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.032623549744531265	27.006756756756758	-34.90410589940028	SMAD4;TGFB1
KEGG_2021_Human	Pancreatic cancer	2/76	0.0037436519554145367	0.032623549744531265	27.006756756756758	-34.90410589940028	SMAD4;TGFB1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.03270997754439886	20.331632653061224	-27.120602948412195	SMAD4;TGFB1
KEGG_2021_Human	Th17 cell differentiation	2/107	0.00729809140286639	0.0335712204531854	18.95952380952381	-25.42995427691617	SMAD4;TGFB1
KEGG_2021_Human	Cell cycle	2/124	0.009704304916610982	0.04058163874219138	16.2827868852459	-22.027132854342252	SMAD4;TGFB1
KEGG_2021_Human	FoxO signaling pathway	2/131	0.010785539693571716	0.041344568825358245	15.385658914728682	-20.853034219946885	SMAD4;TGFB1
KEGG_2021_Human	Gastric cancer	2/149	0.013800829937106646	0.048833705931300445	13.47108843537415	-18.28530462280935	SMAD4;TGFB1
KEGG_2021_Human	Hippo signaling pathway	2/163	0.01637338006583509	0.04984975210558035	12.277950310559007	-16.639197462960915	SMAD4;TGFB1
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.04984975210558035	12.35625	-16.748364182562245	SMAD4;TGFB1
KEGG_2021_Human	Hepatocellular carcinoma	2/168	0.01733904421063664	0.04984975210558035	11.900602409638553	-16.11078229535683	SMAD4;TGFB1
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.07718919308279881	9.044930875576037	-11.980722307867735	SMAD4;TGFB1
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.14582789555828488	18.962174940898347	-11.032973182262484	TGFB1
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.14582789555828488	18.183673469387756	-10.63265628196324	TGFB1
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.07765521083230079	0.173655126134255	13.895833333333334	-8.322075559905016	TGFB1
KEGG_2021_Human	Adherens junction	1/71	0.08454220466511847	0.173655126134255	12.695238095238095	-7.638591016595616	SMAD4
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.173655126134255	13.071895424836601	-7.854937277937848	TGFB1
KEGG_2021_Human	Inositol phosphate metabolism	1/73	0.0868275630671275	0.173655126134255	12.339506172839506	-7.43259286356604	ITPKC
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.17515052434385228	11.68421052631579	-7.04872976578505	TGFB1
KEGG_2021_Human	Phosphatidylinositol signaling system	1/97	0.11385418156418702	0.1893824252982587	9.226851851851851	-5.553951626329874	ITPKC
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.1893824252982587	9.32514619883041	-5.615549699272252	TGFB1
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.1893824252982587	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.1893824252982587	9.961298377028713	-6.010407578745034	TGFB1
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.1893824252982587	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.1934642111996221	8.189300411522634	-4.893732148578802	TEK
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.1934642111996221	7.964964964964965	-4.748494648054986	TGFB1
KEGG_2021_Human	Pathways in cancer	2/531	0.13679480156092927	0.19664252724383582	3.5628544423440456	-3.410136075895621	SMAD4;TGFB1
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.20127634939412276	6.892361111111111	-4.041189892105298	TGFB1
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.20127634939412276	7.00352733686067	-4.115510268264927	TGFB1
KEGG_2021_Human	Apelin signaling pathway	1/137	0.15730251033809037	0.20674044215863305	6.480392156862745	-3.763669230249352	SMAD4
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	1/143	0.163651680714637	0.2091104809131473	6.2018779342723	-3.57415842622014	SMAD4
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.214578809694181	5.70995670995671	-3.235678410841787	TGFB1
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.214578809694181	5.672401433691756	-3.209640069203435	TGFB1
KEGG_2021_Human	Wnt signaling pathway	1/166	0.1875932968535885	0.22126388859654028	5.321885521885521	-2.9652743858654524	SMAD4
KEGG_2021_Human	Axon guidance	1/182	0.2038826300760579	0.2287463654511869	4.841620626151013	-2.6265948500338347	RASA1
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.2287463654511869	4.896958410924891	-2.6658400097237527	TGFB1
KEGG_2021_Human	Rap1 signaling pathway	1/210	0.23168307497366095	0.24221412383610008	4.178096757044125	-2.1518791496475385	TEK
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.24221412383610008	4.283224400871459	-2.2275706216550177	TGFB1
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.24221412383610008	4.326732673267327	-2.2588473265567357	TGFB1
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.2662857800477916	3.6397024639702464	-1.7619943041292825	ITPKC
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.36133488698431165	2.4283915643689014	-0.883914601009246	TEK
